Heart Disease News and Research

Latest Heart Disease News and Research

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for and is beginning the U.S. launch of the SMARTVIEW remote monitoring solution for patients with implanted cardiac rhythm management devices.

13 May 2013

Who is responsible for retired football players' medical costs?

Who should bear the costs of football-related medical problems that arise years after retirement? This question is at the heart of Williams's case - and scores of others like it.

13 May 2013

WVU ICRH director named 2013 Rural Health Practitioner of the Year

Larry Rhodes, M.D., interim chair of the West Virginia University Department of Pediatrics and director of the WVU Institute for Community and Rural Health, has been named the 2013 Rural Health Practitioner of the Year by the National Rural Health Association.

13 May 2013

Viewpoints: The threat from 'contagion exhaustion;' An economist sees humor in hospital pricing

There has been a flurry of recent attention over two novel infectious agents: the first, a strain of avian influenza virus (H7N9) in China that is causing severe respiratory disease and other serious health complications in people; the second, a coronavirus, first reported last year in the Middle East, that has brought a crop of new infections.

13 May 2013

Research on total anomalous pulmonary venous connection

Total anomalous pulmonary venous connection, one type of "blue baby" syndrome, is a potentially deadly congenital disorder that occurs when pulmonary veins don't connect normally to the left atrium of the heart.

13 May 2013

New research shows that spontaneous mutations contribute to congenital heart disease

Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease. Many of these defects can be repaired though surgery, but researchers don't understand what causes them or how to prevent them. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.

13 May 2013

Findings to help researchers study causes of congenital heart disease in future

Findings from the first large-scale sequencing analysis of congenital heart disease bring us closer to understanding this most common type of birth defect. The analysis found that spontaneous, or de novo, mutations affect a specific biological pathway that is critical to aspects of human development, including the brain and heart.

13 May 2013

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.

13 May 2013

Researchers identify clue to explain the reversible memory loss caused by statins

The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs.

13 May 2013

New 3-D technology to see precise source of atrial fibrillation in the heart

Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed a new 3-D technology that for the first time allows cardiologists the ability to see the precise source of atrial fibrillation in the heart - a breakthrough for a condition that affects nearly three million Americans.

13 May 2013

Private insurers have cost Medicare almost $300 billion more over the life of the program

A study published online today finds that the private insurance companies that participate in Medicare under the Medicare Advantage program and its predecessors have cost the publicly funded program for the elderly and disabled an extra $282.6 billion since 1985, most of it over the past eight years. In 2012 alone, private insurers were overpaid $34.1 billion.

13 May 2013

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

13 May 2013

Journal provides guidance for clinicians on prescribing exercise for depressed patients

Exercise has been shown to be an effective treatment for major depressive disorder, both when used alone and in combination with other treatments.

13 May 2013

New British technologies are transforming healthcare and saving lives

Innovative projects including: smart-phone test and tracking systems for infectious diseases; fibre optic probes that can monitor people's condition in intensive care; and in-home sensors that can relay patient information to doctors immediately, have benefitted from a -32 million investment.

10 May 2013

Operating without interrupting warfarin treatment during cardiac device surgery reduces hematomas

A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care.

10 May 2013

Nutritional supplement may improve survival rates of babies born with heart defects

A common nutritional supplement may be part of the magic in improving the survival rates of babies born with heart defects, researchers report. Carnitine, a compound that helps transport fat inside the cell powerhouse where it can be used for energy production, is currently used for purposes ranging from weight loss to chest pain.

10 May 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

Who is responsible for retired football players' medical costs?

WVU ICRH director named 2013 Rural Health Practitioner of the Year

Viewpoints: The threat from 'contagion exhaustion;' An economist sees humor in hospital pricing

Research on total anomalous pulmonary venous connection

New research shows that spontaneous mutations contribute to congenital heart disease

Findings to help researchers study causes of congenital heart disease in future

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Researchers identify clue to explain the reversible memory loss caused by statins

New 3-D technology to see precise source of atrial fibrillation in the heart

Private insurers have cost Medicare almost $300 billion more over the life of the program

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Journal provides guidance for clinicians on prescribing exercise for depressed patients

New British technologies are transforming healthcare and saving lives

Operating without interrupting warfarin treatment during cardiac device surgery reduces hematomas

Nutritional supplement may improve survival rates of babies born with heart defects

First Edition: May 10, 2013

AACN to present GE Healthcare-AACN Pioneering Spirit Award to JoAnn Grif Alspach

AACN to bestow 2013 Circle of Excellence Award on 25 nurses nationwide

People who experience more upbeat emotions have better physical health

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in